替凡尼替是一种新型的高选择性c-Met酪氨酸激酶抑制剂,Ki 为 355 nM,是一种实验性的小分子抗癌药物。这是一个双吲哚基马来酰亚胺,结合去磷酸化的Met激酶体外。(TMT是一种生长因子受体)。

清空选项
1912-33-0 Methyl 2-(1H-indol-3-yl)acetate
BD130291912-33-097%
¥33.001g常备现货
124730-56-9 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-carboxylic acid
BD160240124730-56-995%
¥6369.001g
345264-02-0 Methyl 2-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-2-oxoacetate
BD331351345264-02-098%
¥8605.001g
1239986-50-5 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione
BD1642311239986-50-598%
¥33690.005g
124730-53-6 Ethyl 5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-carboxylate
BD237917124730-53-698%
¥9471.001g
345261-20-3 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione
BD224186345261-20-395+%
¥25567.001g
1